NCT06821425View on ClinicalTrials.gov

Melatonin Gel as an Adjuvant in the Surgical Management of Intrabony Defects

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

August 1, 2025

Study Completion Date

August 1, 2025

Conditions
Periodontal Disease, AVDC Stage 3
Interventions
DRUG

Melatonin gel mixed with xenograft

This study will be conducted to evaluate the effect of melatonin (5% gel) when used as an adjunct to xenograft for the surgical management of intrabony periodontal defects.

OTHER

Xenograft

Application of Xenograft alone for the surgical management of intrabony periodontal defects.

Trial Locations (1)

11511

Faculty of Dentistry, Ain Shams University, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT06821425 - Melatonin Gel as an Adjuvant in the Surgical Management of Intrabony Defects | Biotech Hunter | Biotech Hunter